MedPath

Investigating the Safety and Performance of SenSura Test Product in Subjects With Ileostomy

Not Applicable
Completed
Conditions
Stoma Ileostomy
Interventions
Device: SenSura
Device: SenSura test product
Registration Number
NCT02887144
Lead Sponsor
Coloplast A/S
Brief Summary

The aim of the current Investigation is to evaluate the safety and performance of SenSura test product 1pc flat and convex light compared with commercial SenSura.

Detailed Description

Investigators want to measure degree of leakage on a 4-point scale of SenSura and SenSura test product.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Be able to handle the products themselves
  4. Have an ileostomy (end or loop ostomy) with a diameter between 10 - 40 mm
  5. Have had their ileostomy for at least 3 months
  6. Have used a 1-piece flat or convex light ostomy appliance with an open bag within the last month
  7. Currently using midi or maxi bags
  8. Willing to use minimum 1 product every second day (max. 2 days wear time)
  9. Be mentally and physically capable of understanding and following the study procedures and completing the Case Report Form
  10. Must be able to cut products themselves
Exclusion Criteria
  1. Currently receiving or have received within the past 2 months chemo- or/and radiation therapy
  2. Currently receiving or have received within the past month local or systemic steroid treatment in the peristomal area
  3. Are pregnant or breastfeeding
  4. Participating in other interventional clinical investigations or have previously participated in this investigation
  5. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
  6. Known hypersensitivity of the product components and/or ingredients

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
SenSura 1pcSenSura test productSubjects randomized to treatment sequence 2 test: 1. SenSura 2. SunSura test product
SenSura test product 1pcSenSuraSubjects randomized to treatment sequence 1test: 1. SenSura test product 2. SenSura
SenSura test product 1pcSenSura test productSubjects randomized to treatment sequence 1test: 1. SenSura test product 2. SenSura
SenSura 1pcSenSuraSubjects randomized to treatment sequence 2 test: 1. SenSura 2. SunSura test product
Primary Outcome Measures
NameTimeMethod
Degree of leakagepatients will test the products for 4 weeks

Leakage under and outside the baseplate will be assessed by a 4 point leakage scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Coloplast A/S

🇩🇰

Humlebaek, Denmark

© Copyright 2025. All Rights Reserved by MedPath